메뉴 건너뛰기
Drugs
Volumn 67, Issue 13, 2007, Pages 1944-1945
Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: A viewpoint by Helio Tedesco Silva Jr
Author keywords

[No Author keywords available]
Indexed keywords

ADVAGRAF; CYCLOSPORIN; TACROLIMUS; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;
EID: 34548351290     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200767130-00014     Document Type: Note
Times cited : (3)
References (4)
  • 1
    • 33645694582 scopus 로고    scopus 로고
    • Immunosuppression: Evolution in practice and trends, 1994-2004
    • May;
    • Meier-Kriesche H-U, Li S, Gruessner RWG, et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 2006 May; 6 (5 Pt 2): 1111-31
    • (2006) Am J Transplant , vol.6 , Issue.5 PART 2 , pp. 1111-1131
    • Meier-Kriesche, H.-U.1    Li, S.2    Gruessner, R.W.G.3
  • 2
    • 33847758317 scopus 로고    scopus 로고
    • Silva Jr HT, Yang HC, Abouljoud M, et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients [published erratum appears in Am J Transplant 2007; 7 (6): 1682]. Am J Transplant 2007 Jan 11; 7 (3): 595-608
    • Silva Jr HT, Yang HC, Abouljoud M, et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients [published erratum appears in Am J Transplant 2007; 7 (6): 1682]. Am J Transplant 2007 Jan 11; 7 (3): 595-608
  • 3
    • 34548322117 scopus 로고    scopus 로고
    • US National Institutes of Health. A study to evaluate the safety and efficacy of FK506E (MR4) in patients undergoing primary kidney transplantation (ClinicalTrials.gov identifier NCT00189839) [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 2007 Jun 5]
    • US National Institutes of Health. A study to evaluate the safety and efficacy of FK506E (MR4) in patients undergoing primary kidney transplantation (ClinicalTrials.gov identifier NCT00189839) [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 2007 Jun 5]
  • 4
    • 0035662562 scopus 로고    scopus 로고
    • Aminoglycoside nephrotoxicity: Do time and frequency of administration matter?
    • Dec;
    • Beauchamp D, Labrecque G. Aminoglycoside nephrotoxicity: do time and frequency of administration matter? Curr Opin Crit Care 2001 Dec; 7 (6): 401-8
    • (2001) Curr Opin Crit Care , vol.7 , Issue.6 , pp. 401-408
    • Beauchamp, D.1    Labrecque, G.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.